| 1 |
LIBSVM
Chih-Chung Chang, Chih‐Jen Lin · ACM Transactions on Intelligent Systems and Technology
|
Apr 2011 |
41,500 |
| 2 |
Unit root tests in panel data: asymptotic and finite-sample properties
Andrew Levin, Chien‐Fu Lin, Chia-Shang James Chu · Journal of Econometrics
|
May 2002 |
12,910 |
| 3 |
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
Marie Ng et al. · The Lancet
Open access140 authors |
28 May 2014 |
12,158 |
| 4 |
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Théry et al. · Journal of Extracellular Vesicles
Open access382 authors |
23 Nov 2018 |
11,535 |
| 5 |
Planck 2015 results
Peter A. R. Ade et al. · Astronomy and Astrophysics
Open access261 authors |
20 Jun 2016 |
10,771 |
| 6 |
Inference and analysis of cell-cell communication using CellChat
Suoqin Jin, Christian Fernando Guerrero‐Juarez, Lihua Zhang et al. · Nature Communications
Open access |
17 Feb 2021 |
8,891 |
| 7 |
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Tony S.K. Mok, Yi-Long Lung Cancer Wu, Sumitra Thongprasert et al. · New England Journal of Medicine
Open access |
19 Aug 2009 |
8,331 |
| 8 |
The automated computation of tree-level and next-to-leading order differential cross sections, and their matching to parton shower simulations
Johan Alwall, Rikkert Frederix, Stefano Frixione et al. · Journal of High Energy Physics
Open access |
Jul 2014 |
7,957 |
| 9 |
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Mohammad Hossein Forouzanfar et al. · The Lancet
Open access654 authors |
Oct 2016 |
7,829 |
| 10 |
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al. · New England Journal of Medicine
Open access |
13 May 2020 |
7,547 |
| 11 |
cytoHubba: identifying hub objects and sub-networks from complex interactome
Chia-Hao Chin, Shu-Hwa Chen, Hsin-Hung Wu et al. · BMC Systems Biology
Open access |
Dec 2014 |
7,025 |
| 12 |
LIBLINEAR: A Library for Large Linear Classification
Rong-En Fan, Kai‐Wei Chang, Cho‐Jui Hsieh et al.
|
Jun 2008 |
6,609 |
| 13 |
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al. · The Lancet
Open access679 authors |
7 Jun 2015 |
6,558 |
| 14 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Chih‐Cheng Lai, Tzu-Ping Shih, Wen‐Chien Ko et al. · International Journal of Antimicrobial Agents
Open access |
17 Feb 2020 |
6,402 |
| 15 |
Electrocatalysis for the oxygen evolution reaction: recent development and future perspectives
Nian‐Tzu Suen, Sung‐Fu Hung, Quan Quan et al. · Chemical Society Reviews
Review |
2017 |
6,312 |
| 16 |
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al. · Autophagy
Open access2,467 authors |
2 Jan 2016 |
6,023 |
| 17 |
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner et al. · Blood
Open access |
28 Nov 2016 |
5,972 |
| 18 |
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann‐Lii Cheng et al. · The Lancet Oncology
|
18 Dec 2008 |
5,881 |
| 19 |
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al. · The Lancet
Open access |
Mar 2018 |
5,578 |
| 20 |
Planck 2015 results
Ade, PAR et al. · ORCA Online Research @Cardiff (Cardiff University)
Open access261 authors |
Oct 2016 |
5,452 |
| 21 |
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al. · Nature
Open access |
28 Oct 2015 |
5,240 |
| 22 |
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Martine J Piccart et al. · New England Journal of Medicine
Open access |
20 Oct 2005 |
5,138 |
| 23 |
A Practical Guide to Support Vector Classication
Chih‐Wei Hsu, Chih-Chung Chang, Chih‐Jen Lin
|
2008 |
5,064 |
| 24 |
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al. · The Lancet
Open access |
20 Apr 2017 |
4,384 |
| 25 |
First M87 Event Horizon Telescope Results. I. The Shadow of the Supermassive Black Hole
Kazunori Akiyama et al. · The Astrophysical Journal Letters
Open access348 authors |
9 Apr 2019 |
4,300 |
| 26 |
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al. · The Lancet
Open access |
5 Dec 2016 |
3,732 |
| 27 |
Artificial Intelligence in Service
Ming‐Hui Huang, Roland T. Rust · Journal of Service Research
Open access |
5 Feb 2018 |
3,516 |
| 28 |
The tomato genome sequence provides insights into fleshy fruit evolution
Hideki Hirakawa et al. · Nature
Open access271 authors |
May 2012 |
3,442 |
| 29 |
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Ann Burtness et al. · The Lancet
Open access219 authors |
Nov 2019 |
3,344 |
| 30 |
A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae
Jinshui Zheng, Stijn Wittouck, Elisa Salvetti et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
Open access |
Apr 2020 |
3,325 |
| 31 |
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
Stephen D. Bentley et al. · Nature
|
May 2002 |
3,297 |
| 32 |
Discovery of a Weyl fermion semimetal and topological Fermi arcs
Su-Yang Xu et al. · Science
Open access |
16 Jul 2015 |
3,296 |
| 33 |
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Hartmut Döhner et al. · Blood
Open access |
7 Jul 2022 |
3,286 |
| 34 |
Advances in molecular quantum chemistry contained in the Q-Chem 4 program package
Yihan Shao et al. · Molecular Physics
157 authors |
3 Sep 2014 |
3,174 |
| 35 |
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chien‐Jen Chen · JAMA
|
3 Jan 2006 |
3,164 |
| 36 |
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David H Adams et al. · New England Journal of Medicine
Open access |
4 Jul 2018 |
3,046 |
| 37 |
Mortality risk attributable to high and low ambient temperature: a multicountry observational study
Antonio Gasparrini et al. · The Lancet
Open access |
21 May 2015 |
3,009 |
| 38 |
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al. · Blood
Open access |
29 Jun 2022 |
2,906 |
| 39 |
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Vassily Vladimirovich Trubetskoy et al. · Nature
Open access613 authors |
8 Apr 2022 |
2,894 |
| 40 |
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
R. Palmer Beasley, Chia‐Chin Lin, Lu‐Yu Hwang et al. · The Lancet
|
Nov 1981 |
2,879 |
| 41 |
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber, David H. Baxter, Shile Zhang et al. · Clinical Chemistry
Open access |
17 Sep 2010 |
2,779 |
| 42 |
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa‐Silva et al. · Nature Cell Biology
Open access |
18 May 2015 |
2,775 |
| 43 |
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Gϋnter von Minckwitz et al. · New England Journal of Medicine
Open access |
5 Dec 2018 |
2,689 |
| 44 |
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
Fabrice André, Eva M. Ciruelos, Gábor Rubovszky et al. · New England Journal of Medicine
Open access |
15 May 2019 |
2,660 |
| 45 |
Detecting Causality in Complex Ecosystems
George Sugihara, Robert Mccredie May, Hao Ye et al. · Science
|
21 Sep 2012 |
2,648 |
| 46 |
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Shiv Kumar Sarin et al. · Hepatology International
Open access |
13 Nov 2015 |
2,603 |
| 47 |
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew Xiuxuan Zhu et al. · The Lancet Oncology
|
3 Jun 2018 |
2,555 |
| 48 |
Planck 2018 results
Y. Akrami et al. · Astronomy and Astrophysics
Open access175 authors |
9 Oct 2019 |
2,504 |
| 49 |
Janus monolayers of transition metal dichalcogenides
Ang‐Yu Lu, Hanyu Zhu, Jun Xiao et al. · Nature Nanotechnology
|
15 May 2017 |
2,487 |
| 50 |
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa et al. · New England Journal of Medicine
Open access |
4 Jul 2018 |
2,386 |